ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

GANX Gain Therapeutics Inc

2.96
0.03 (1.02%)
After Hours
Last Updated: 18:04:17
Delayed by 15 minutes

Period:

Draw Mode:

Volume 95,022
Bid Price 2.96
Ask Price 4.00
News -
Day High 3.02

Low
2.00

52 Week Range

High
5.65

Day Low 2.87
Share Name Share Symbol Market Stock Type
Gain Therapeutics Inc GANX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.03 1.02% 2.96 18:04:17
Open Price Low Price High Price Close Price Previous Close
3.00 2.87 3.02 2.96 2.93
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
590 95,022 US$ 2.93 US$ 278,184 - 2.00 - 5.65
Last Trade Type Quantity Price Currency
15:53:10 75 US$ 3.07 USD

Gain Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
37.83M 12.91M - 55k -22.11M -1.71 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Gain Therapeutics News

Date Time Source News Article
4/24/202408:25GlobeNewswire Inc.Gain Therapeutics Announces Positive Results from the Single..
4/08/202408:25GlobeNewswire Inc.Gain Therapeutics Bolsters Management Team with the..
4/01/202408:25GlobeNewswire Inc.Gain Therapeutics Strengthens Management Team and Appoints..
3/26/202407:00GlobeNewswire Inc.Gain Therapeutics Reports Financial Results for Year End..
3/15/202413:30GlobeNewswire Inc.Gain Therapeutics to Present at Public Ventures Discovery..
3/05/202407:00GlobeNewswire Inc.Gain Therapeutics Presents Data at the AD/PD™ 2024..
2/27/202413:00GlobeNewswire Inc.Gain Therapeutics Announces the Initiation of the Multiple..
2/22/202406:00Edgar (US Regulatory)Form 8-K - Current report
2/14/202411:29GlobeNewswire Inc.Gain Therapeutics Announces 2024 R&D Update on Parkinson’s..
2/06/202408:56GlobeNewswire Inc.UPDATE - Gain Therapeutics’ GT-02287 Completely Restores..
2/06/202407:00GlobeNewswire Inc.Gain Therapeutics’ GT-02287 Completely Restores Motor..
1/31/202416:26Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No GANX Message Board. Create One! See More Posts on GANX Message Board See More Message Board Posts

Historical GANX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.093.182.872.9886,403-0.13-4.21%
1 Month3.573.722.873.1786,998-0.61-17.09%
3 Months4.965.302.874.15126,159-2.00-40.32%
6 Months2.715.332.003.80130,6270.259.23%
1 Year5.255.652.003.8786,516-2.29-43.62%
3 Years12.0912.11442.005.0680,518-9.13-75.52%
5 Years11.2217.932.005.6283,255-8.26-73.62%

Gain Therapeutics Description

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements.

Your Recent History

Delayed Upgrade Clock